News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Vivek Subbiah/LinkedIn
Apr 20, 2025, 09:19

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an article by Richard A. Furie, et al. on X:

“Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis:

Obinutuzumab = a humanized type II anti-CD20 monoclonal antibody approved in CLL.

A nice example of drug repurposing.”

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Authors: Richard A. Furie, et al.

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Active Lupus Nephritis cancer CLL drug repurposing early-phase drug development fight against cancer Global fight against cancer Monoclonal Antibody Obinutuzumab OncoDaily Oncology Sarah Cannon Research Institute Vivek Subbiah
Special Coverage
Science
Jun 20, 2025, 16:48
Eddie Cliff: COALITION Study Compares Results of Glofitamab Combinations in LBCL
Positive
Jun 20, 2025, 16:37
Tom Powles: Annals of Oncology is Driving Journal Quality and Impact
Blog
Jun 20, 2025, 16:30
Pashtoon Kasi: Available Research Guiding the Care of Patients with Colorectal Cancer
Blog
Jun 20, 2025, 16:26
Khushali Jhaveri Shares Epcoritamab Combination Results in First-Line DLBCL
Oncolibrary
Jun 20, 2025, 16:17
Cardio-Oncology in Focus: How Chemotherapy Can Harm Heart Health
Blog
Jun 20, 2025, 16:16
Graham Collins: ctDNA in S1826 - Clearance at C3D1 Associated With PFS
Science
Jun 20, 2025, 16:15
Sabine D. Brookman-May: Excellent Review on PSMA PET for Prostate Cancer Diagnosis
Blog
Jun 20, 2025, 16:06
Udhayvir Grewal: Watch Me Discuss the Evolving Role of Bispecific Antibodies in GI Cancers at ASCO25
Blog
Jun 20, 2025, 16:04
Fidel Rubagumya Shared Updates on Rwanda's First Oncology Fellowship and Global Support Since Its Launch
Positive
Jun 20, 2025, 16:02
Honoring the Star Acts of MVR CANCON 2025 - INDEPSO
Blog
Jun 20, 2025, 15:56
Graham Collins: Great Work That Significantly Informs Practice on NLPHL Presented at ICML 2025
Insight
Jun 20, 2025, 15:43
ASCRS Clinical Practice Guidelines on the Management of Appendiceal Neoplasms - DCR Journal